Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism hERG modulators(Voltage-gated potassium channel subunit Kv11.1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H15BrN2O3 |
InChIKeyQNWXOXKHLFTJBA-UHFFFAOYSA-N |
CAS Registry1821638-40-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Long QT Syndrome | Preclinical | NL | 28 Jul 2016 |